مقالات در نشریات
- 21. Arabpour, M., Mehrpour Layeghi, S., Majidzadeh ,& A, K., (...), Naghizadeh, M.M., Shakoori, A.,An insight into the potential role of LINC00968 in luminal breast cancer: Case-control study and bioinformatics analysis,Biochemistry and Biophysics Reports,2023 9 1.
- 22. Rahmanian, M., Sartipzadeh Hematabad, O., Askari, E., (...), den Toonder, J.M.J., Majidzadeh ,& A, K.,A micropillar array-based microfluidic chip for label-free separation of circulating tumor cells: The best micropillar geometry?,Journal of Advanced Research,2023 5 1.
- 23. Rahmanian, M., Sartipzadeh Hematabad, O., Askari, E., (...), den Toonder, J.M.J., Majidzadeh ,& A, K.,A micropillar array-based microfluidic chip for label-free separation of circulating tumor cells: The best micropillar geometry?,Journal of Advanced Research,2023 5 1.
- 24. Ahmadvand, M., Barough, M.S., Hashemi, Z.S., (...), Ghavamzadeh, A., Forooshani, R.S.,Safety and feasibility study of ex vivo expanded allogeneic-NK cells infusion in patients with acute pneumonia caused by COVID-19,Pilot and Feasibility Studies,2023 12 1.
- 25. Abbasi , Kangevari, M., Moghaddam, S.S., Ghamari, S. , H., (...), Yuce, D., Zare, I.,The burden of prostate cancer in North Africa and Middle East, 1990-2019: Findings from the global burden of disease study,Frontiers in Oncology,,2022 9 13.
- 26. Abbasi , Kangevari, M., Moghaddam, S.S., Ghamari, S. , H., (...), Yuce, D., Zare, I.,The burden of prostate cancer in North Africa and Middle East, 1990-2019: Findings from the global burden of disease study,Frontiers in Oncology,,2022 9 13.
- 27. Darvishi, B., Eisavand, M.R., Majidzadeh ,& A, K., Farahmand, L.,Matrix stiffening and acquired resistance to chemotherapy: concepts and clinical significance,British Journal of Cancer,,2022 5 18.
- 28. Darvishi, B., Eisavand, M.R., Majidzadeh ,& A, K., Farahmand, L.,Matrix stiffening and acquired resistance to chemotherapy: concepts and clinical significance,British Journal of Cancer,,2022 5 18.
- 29. Darvishi, B., Eisavand, M.R., Majidzadeh ,& A, K., Farahmand, L.,Matrix stiffening and acquired resistance to chemotherapy: concepts and clinical significance,British Journal of Cancer,,2022 5 18.
- 30. Darvishi, B., Eisavand, M.R., Majidzadeh ,& A, K., Farahmand, L.,Matrix stiffening and acquired resistance to chemotherapy: concepts and clinical significance,British Journal of Cancer,,2022 5 18.
- 31. Samadi, M., Majidzadeh , A, K., Salehi, M., (...), Moradi , Kalbolandi, S., Farahmand, L.,Correction: Engineered hypoxia-responding Escherichia coli carrying cardiac peptide genes, suppresses tumor growth, angiogenesis and metastasis in vivo (Journal of Biological Engineering, (2021), 15, 1, (20), 10.1186/s13036-021-00269-2),Journal of Biological Engineering,2022 12 1.
- 32. Aghayan, H.R., Salimian, F., Abedini, A., (...), Ghavamzadeh, A., Sarrami ,& Forooshani, R.,Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment,Stem Cell Research and Therapy,,2022 12 1.
- 33. Samadi, M., Beigi, L., Yadegari, F., (...), Eskordi, M., Farahmand, L.,Recognition of functional genetic polymorphism using ESE motif definition: a conservative evolutionary approach to CYP2D6/CYP2C19 gene variants,Genetica,,2022 10 1.
- 34. Samadi, M., Beigi, L., Yadegari, F., (...), Eskordi, M., Farahmand, L.,Recognition of functional genetic polymorphism using ESE motif definition: a conservative evolutionary approach to CYP2D6/CYP2C19 gene variants,Genetica,,2022 10 1.
- 35. Merikhian, P., Darvishi, B., Jalili, N., (...), Rahbarizadeh, F., Farahmand, L.,Recombinant nanobody against MUC1 tandem repeats inhibits growth, invasion, metastasis, and vascularization of spontaneous mouse mammary tumors,Molecular Oncology,,2022.
- 36. Majidzadeh ,& A, K., Zarinfam, S., Abdoli, N., (...), Salehi, M., Zamani, M.,A comprehensive reference for BRCA1/2 genes pathogenic variants in Iran: published, unpublished and novel,Familial Cancer,,2022.
- 37. Merikhian, P., Darvishi, B., Jalili, N., (...), Rahbarizadeh, F., Farahmand, L.,Recombinant nanobody against MUC1 tandem repeats inhibits growth, invasion, metastasis, and vascularization of spontaneous mouse mammary tumors,Molecular Oncology,,2022.
- 38. Majidzadeh ,& A, K., Zarinfam, S., Abdoli, N., (...), Salehi, M., Zamani, M.,A comprehensive reference for BRCA1/2 genes pathogenic variants in Iran: published, unpublished and novel,Familial Cancer,,2022.
- 39. Barzaman, K., Samadi, M., Moradi ,& kalbolandi, S., (...), Shekarabi, M., Farahmand, L.,Development of a recombinant anti-VEGFR2-EPCAM bispecific antibody to improve antiangiogenic efficiency,Experimental Cell Research,2021 8 15.
- 40. Sina, M., Ghorbanoghli, Z., Abedrabbo, A., (...), Georgiou, D., Vasen, H.F.A.,Identification and management of Lynch syndrome in the Middle East and North African countries: outcome of a survey in 12 countries,Familial Cancer,2021 7 1.
نمایش ۲۱ تا ۴۰ مورد از کل ۲۳۵ مورد.